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amounts of IFNb in the absence of MITA.
Mechanistically, the intracellular localiza-
tion of MITA and the role of its membrane
localization should be clarified. The asso-
ciation of MITA with the ER translocon
complex is intriguing, but how the translo-
con complex plays a role in IFNb induction
remains to be elucidated. The biochemi-
cal mechanism by which MITA mediates
IFNb induction by cytosolic DNA is
another promising area of future explora-
tion, and this line of research may facili-
tate the discovery of a cytosolic DNA
sensor (or sensors).
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Natural killer cell inhibitory receptors block effector responses by recruiting phosphatases that dephosphor-
ylate molecules involved in activation. However, in this issue of Immunity, Peterson and Long show that
inhibitory receptors also signal tyrosine phosphorylation, an event usually indicating cellular activation.A defining feature of natural killer (NK)
cell recognition of cellular targets is the
presence of inhibitory receptors specific
for target cell MHC class I molecules
(Yokoyama, 2008). In mice, these recep-
tors are type II integral membrane
proteins with C-type lectin-like domains
(predominantly the Ly49 family of recep-
tors), whereas human NK cells utilize
primarily type I integralmembraneproteins
with immunoglobulin (Ig)-like domains,
termed killer Ig-like receptors (KIRs), in
an example of convergent evolution. In ad-
dition, NK cells from both species express
the lectin-like CD94-NKG2A inhibitory re-
ceptors for HLA-E and Qa-1. Regardless
of these striking differences in structure
and topology, both structural types of in-
hibitory receptors block effector functions
triggered by NK cell activation receptors.
In this issue, Peterson and Long describe
new insight into the mechanism of inhibi-
tory-receptor signaling (Peterson and
Long, 2008).
Upon ligand engagement, the immu-
noreceptor tyrosine-based inhibitory mo-tifs (ITIMs) in the cytoplasmic tails of the
inhibitory receptors are phosphorylated
by Src family tyrosine kinases. In contrast
to activation-receptor motifs that initiate
tyrosine-kinase-signaling cascades, the
phosphorylated ITIMs bind several phos-
phatases, including the tyrosine phospha-
tases, SHP-1 (Src homology region 2
domain-containing phophatase-1) and
SHP-2, and the inositol phosphatase,
SHIP. Among these, the NK cell inhibitory
receptors preferentially recruit and
activate SHP-1, which is required for inhi-
bition. The consensus view has been that
the phosphatases then dephosphorylate
molecules in activation-receptor-signal-
ing cascades (Figure 1). Considerable
effort has been expended to identify the
target(s) of SHP-1 for determining
whether it directly dephosphorylates
many substrates or only specific targets
in the context of NK cell inhibitory-recep-
tor function. Addressing this issue is chal-
lenging because both possibilities could
result in global decreases in activation-
induced tyrosine phosphorylation, eitherImmunity 29directly or downstream of a specific target
that fails to transmit the activation signal.
To determinewhether SHP-1 has a spe-
cific target in human NK cells, the Long
laboratory previously employed an NK
cell line expressing defined KIRs and
exposed it to targets expressing HLA
ligands for the KIR of interest, rather
than antibody crosslinking (Stebbins et al.,
2003). Furthermore, they utilized a ‘‘trap-
ping’’ mutant of SHP-1 that had amutation
in the critical catalytic residue yet was
still able to bind and trap substrate. The
SHP-1 mutant was fused to the cytoplas-
mic domain of a KIR, allowing identifica-
tion of SHP-1 substrates that specifically
resulted from KIR interactions with cog-
nate ligand HLA. Vav1 was thus identified
as a specific target of SHP-1 in human NK
cells (Figure 1); those observations were
extended in the current paper to another
human NK cell line (Peterson and Long,
2008).
Vav1 belongs to a family of guanine
nucleotide exchange factors for the Rho
family of GTPases, and Vav proteins play, October 17, 2008 ª2008 Elsevier Inc. 515
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Phosphorylation
NK cell inhibitory receptors recognize HLA class I molecules, resulting in phosphorylation of their ITIMs by
Src family tyrosine kinases. SHP-1 is then recruited and activated to dephosphorylate a specific target,
Vav1. In addition, inhibitory-receptor signaling results in the association of c-Abl with Crk and tyrosine
phosphorylation of Crk. Although the connection between the ITIM and c-Abl is not clear, both events
lead to inhibition of NK cell effector responses.important roles in lymphocyte-receptor
signaling and actin cytoskeletal rear-
rangements (Swat and Fujikawa, 2005).
Studies of mutant mice lacking one or
more of the three Vav isoforms have re-
vealed an important role of Vav proteins
in NK cell activation-receptor signaling,
with each isoform contributing somewhat
differently to signaling by specific activa-
tion receptors. Thus, it appeared that
dephosphorylation of Vav proteins should
be sufficient to block NK cell activation,
thereby explaining the inhibitory signaling
pathway via the ITIMs and SHP-1.
There are other considerations with
the Vav family members, however. These
molecules contain several domains for
interaction with other signaling compo-
nents, including adaptors and molecular
scaffolds. Indeed, Peterson and Long
now show that NK cell activation leads to
tyrosine phosphorylation of Vav1 and
association with a previously identified
interacting molecule, c-Cbl, which is also
tyrosine phosphorylated. c-Cbl contains
numerous protein-interaction domains
(Schmidt and Dikic, 2005). During NK
cell activation by target cells, c-Cbl is as-
sociated with a macromolecular complex
consisting of the adaptor Crk (either CrkII
or CrkL, depending on the cell), the
scaffold protein p130CAS (130 kDa Crk-
associated substrate) and C3G (Crk SH3
domain-binding guanine-nucleotide ex-
change factor). Thus, activation receptor516 Immunity 29, October 17, 2008 ª2008 Esignaling through Vav leads to formation
of c-Cbl complexes.
Importantly, formation of c-Cbl com-
plexes with Crk, p130CAS, and C3G is
critical for signaling in a wide variety of
cellular pathways including Rap1 GTPase
activation, actin reorganization, cell adhe-
sion, and MAP-kinase activation (Feller,
2001). Although c-Cbl is also a ubiquitin
E3 ligase, Peterson and Long find no evi-
dence that this function plays a role in NK
cell signaling. Not surprisingly, ligand en-
gagement of either KIR or the lectin-
like receptor CD94-NKG2A blocks the
formation of Cbl-Crk-p130CAS-C3G
complexes. Similar effects were seen
with primary NK cells, consistent with
blockade of activation events by the
inhibitory receptors.
Surprisingly, however, Peterson and
Long observed that inhibitory-receptor
engagement induced unique events
that were not seen with activation-
receptor signaling. Ligand engagement
of either KIR or CD94-NKG2A induced
the association of the tyrosine kinase
c-Abl with Crk (Figure 1). Furthermore, in-
hibitory-receptor engagement induced
tyrosine phosphorylation of Crk at a
regulatory Tyr at residue 221 (Tyr221),
presumably by c-Abl. In other words, in-
hibitory-receptor engagement activated
signaling events.
Peterson and Long further demon-
strated that tyrosine phosphorylation oflsevier Inc.Crk contributes to inhibitory-receptor sig-
naling. As a result of technical details, they
settled on an approach involving trans-
duced expression of a chimeric form of
Crk with plasma-membrane-localization
signal from Lyn. This allowed them to
bypass the requirement for Tyr221 phos-
phorylation of Crk for its localization to the
plasma membrane, where it can recruit
relevant downstream partners. Cells ex-
pressing this chimeric molecule inhibited
NK cell killing, whereas inhibition was re-
versed with a Phe mutation at Tyr221.
Thus, these data suggest that Crk phos-
phorylation is involved in inhibitory-recep-
tor signaling.
There are many details to be worked
out. It is not clear whether Vav is involved
in transmitting signals from the inhibitory
receptor for Crk phosphorylation. Maybe
this is due to Crk association with SHP1-
Vav1-Cbl via direct interaction with
c-Cbl. If not, how is Crk phosphorylation
coupled to the ITIM? How is c-Abl
activated to phosphorylate Crk during
inhibition? Peterson and Long also specu-
late that Crk phosphorylation leads to
disassembly of Cbl-Crk-p130CAS-C3G
complexes. Although this hypothesis
requires further testing, it implies that in-
hibitory-receptor signaling is specifically
focused on preventing formation of Cbl-
Crk-p130CAS-C3G complexes (through
Vav dephosphorylation) and on disas-
sembling already formed complexes
(through Crk phosphorylation), a burning
of the candle from both ends, so to speak.
Alternatively, they speculate that different
aspects of cellular activation may be
controlled by Vav and Crk signals inde-
pendently. Thus, there is ample fodder
for future detailed biochemical studies of
inhibitory-receptor signaling.
The current studies clearly indicate that
inhibitory-receptor signaling is more com-
plex than previously realized. In addition
to association of c-Abl with Crk, each
could potentially recruit other signaling
molecules, because both have numerous
protein-interaction domains, suggesting
that other events may be signaled, includ-
ing events conventionally associated with
activation. The ultimate downstream out-
come could be affected by the spatial
and temporal cascade of molecules
recruited to a macromolecular complex,
as well as the availability of relevant sub-
strates. In different cells, conditions, or
contexts, the final outcomes could be
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receptor-ligand pair initiates the signals
at the plasma membrane.
The induction of tyrosine phosphoryla-
tion by inhibitory-receptor engagement
drives home the message that the term
‘‘inhibitory receptor’’ may not always
mean that it can only block activation
events; we must remember that the term
was coined to describe these receptors
on the basis of their function during the ef-
fector responses of NK cells. Instead, the
paper by Peterson and Long indicates
that the receptors transmit signals that
can be interpreted as activation or inhibi-
tion, depending on the context, and that
it is too simplistic to consider the inhibi-
tory receptors as only being inhibitory.
Although it may be easier to use the ‘‘in-
hibitory receptor’’ label out of conve-
nience and historical precedence, it may
also be myopic if it restricts our thinking
to the idea that these receptors can only
be inhibitory.
Indeed, the MHC-specific receptors on
NK cells have an ITIM-dependent func-
tion, apart from regulating effector re-
sponses. In a process termed ‘‘licensing,’’
which is relevant to NK cell tolerance for
self, engagement of a self-MHC-specific
receptor with its cognate MHC class I
ligand allows an NK cell to have the
functional competence to be triggered
through its activation receptors (Kim et al.,
2005). Although the self-MHC-specific
receptors involved in licensing are the
same ones that inhibit NK cell function in
effector responses, there are at least two
major hypotheses as to how their engage-
ment could lead to the licensed state
(Raulet and Vance, 2006). The ‘‘arming’’model suggests that the receptors di-
rectly trigger events that lead to licensing,
akin to an activation receptor. Another
possibility is that the self-specific recep-
tors block the action of a putative self-
specific activation receptor that, if unim-
peded, leads to an anergic-like state. In
this second possibility, the self-MHC-
specific receptor acts like an inhibitory
receptor to ‘‘disarm’’ the NK cell. Until
recently, data were not available for direct
testing of these models.
Regarding the disarming model, recent
insight has come from studies in mice
transgenic for activation-receptor ligands
(Sun and Lanier, 2008; Tripathy et al.,
2008). NK cells bearing the cognate
receptors are hyporesponsive, as pre-
dicted by the disarming model. However,
self-MHC-specific-receptor engagement
did not affect this hyporesponsiveness
(Tripathy et al., 2008), suggesting that
chronic engagement of an activation
receptor is a separate tolerance mecha-
nism. Although it is possible that affinity
or avidity differences of either the activa-
tion or the self-MHC-specific receptor-
ligand pair could affect the anergic state,
the current data nevertheless do not
support the disarming model.
Consistent with the armingmodel for an
explanation of licensing, the current re-
sults from Peterson and Long strongly
hint that the inhibitory receptors could
deliver other signals, with different
outcomes. As a result of combinatorial as-
sociation of signaling molecules or events
triggered by c-Abl tyrosine kinase, the
self-MHC-specific receptors may, in fact,
directly trigger signals that allow the NK
cell to become licensed. Exploration ofImmunity 2these possibilities will be aided by addi-
tional biochemical characterization of
inhibitory-receptor signaling in effector
responses.
Finally, the advances provided by
Peterson and Long are likely to be very
relevant to other ITIM-dependent inhibi-
tory receptors on NK cells for non-MHC
ligands. Moreover, other hematopoietic
cells express related ITIM-dependent
inhibitory receptors. Therefore, it seems
likely that there will be a resurgence of
interest in how inhibitory receptors signal,
not only inhibition but also activation.
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